Colorectal cancer is the third most common cancer and the third leading cause of cancer-related mortality in both men and women in the United States. Colorectal cancer is highly preventable with regular screening, such as colonoscopy. Once a patient is diagnosed with colorectal cancer, it is highly curable when detected at an early stage.
Providence Colorectal Cancer Program offers state-of-the-art diagnostic and minimally invasive surgical options for patients with cancer of the intestinal tract, rectum, anus or peri-anal area. The program brings together experts in highly specialized areas to work as a multidisciplinary, patient-focused team.
Our program works with patients throughout the continuum of care from screening and diagnostic procedures to cancer treatment and surveillance. Providence is there for patients every step of the way.
Program components include:
Our program is led by Mark H. Whiteford, M.D., F.A.C.S., F.A.S.C.R.S., a physician and surgeon who specializes in minimally-invasive treatment of colon and rectal cancer, diverticulitis, ulcerative colitis and Crohn’s disease. Dr. Whiteford is a leader in the use of laparoscopic surgery for colorectal cancer, and he is one of a handful of surgeons nationally practicing transanal endoscopic microsurgery (TEM), a highly-specialized, minimally-invasive technique to remove large rectal polyps and early rectal cancers.
Enter your ZIP to see local news and info